Prothena Corp SHS Call Option
(PRTA)
|
12.6 |
$284M |
|
11M |
25.12 |
Xencor
(XNCR)
|
9.4 |
$211M |
|
4.9M |
43.06 |
Morphic Hldg
(MORF)
|
8.4 |
$190M |
|
3.0M |
63.28 |
Anaptysbio Inc Common
(ANAB)
|
6.8 |
$154M |
|
7.2M |
21.55 |
Nuvation Bio Com Cl A
(NUVB)
|
6.1 |
$138M |
|
13M |
10.45 |
Relay Therapeutics
(RLAY)
|
5.3 |
$119M |
|
3.4M |
34.57 |
Silverback Therapeutics
(SPRY)
|
4.9 |
$111M |
|
2.5M |
43.63 |
Kura Oncology
(KURA)
|
4.6 |
$104M |
|
3.7M |
28.27 |
Mirati Therapeutics
|
3.5 |
$80M |
|
464k |
171.30 |
Oric Pharmaceuticals
(ORIC)
|
3.4 |
$76M |
|
3.1M |
24.50 |
Shattuck Labs
(STTK)
|
3.2 |
$72M |
|
2.5M |
29.24 |
Nurix Therapeutics
(NRIX)
|
2.8 |
$63M |
|
2.0M |
31.09 |
Arcus Biosciences Incorporated
(RCUS)
|
2.7 |
$62M |
|
2.2M |
28.08 |
Solid Biosciences
|
2.3 |
$51M |
|
9.2M |
5.53 |
Avidity Biosciences Ord
(RNA)
|
2.0 |
$46M |
|
2.1M |
21.81 |
Edgewise Therapeutics
(EWTX)
|
1.8 |
$40M |
|
1.2M |
32.50 |
Neoleukin Therapeutics
|
1.7 |
$38M |
|
3.1M |
12.31 |
Atreca Cl A Com
(BCEL)
|
1.6 |
$37M |
|
2.4M |
15.33 |
Design Therapeutics
(DSGN)
|
1.5 |
$34M |
|
1.1M |
29.90 |
Gritstone Oncology Ord
(GRTS)
|
1.4 |
$32M |
|
3.4M |
9.43 |
Ac Immune Sa SHS
(ACIU)
|
1.2 |
$28M |
|
3.6M |
7.61 |
Akouos
|
1.2 |
$27M |
|
2.0M |
13.87 |
Ovid Therapeutics
(OVID)
|
1.1 |
$24M |
|
6.1M |
4.02 |
Arvinas Ord
(ARVN)
|
0.9 |
$21M |
|
319k |
66.10 |
Chinook Therapeutics
|
0.9 |
$19M |
|
1.3M |
15.54 |
Alector
(ALEC)
|
0.5 |
$12M |
|
603k |
20.14 |
Eledon Pharmaceuticals
(ELDN)
|
0.5 |
$12M |
|
1.1M |
10.70 |
Kronos Bio
(KRON)
|
0.5 |
$11M |
|
387k |
29.27 |
Applied Molecular Trans
|
0.5 |
$11M |
|
239k |
44.01 |
Allovir
(ALVR)
|
0.5 |
$11M |
|
447k |
23.40 |
Nuvation Bio *w Exp 07/07/202
(NUVB.WS)
|
0.4 |
$10M |
|
963k |
10.45 |
Translate Bio
|
0.4 |
$9.8M |
|
597k |
16.49 |
Bctg Acquisition Corp
|
0.4 |
$8.9M |
|
800k |
11.12 |
Iteos Therapeutics
(ITOS)
|
0.4 |
$8.9M |
|
260k |
34.18 |
Alpine Immune Sciences
(ALPN)
|
0.3 |
$7.9M |
|
741k |
10.60 |
Syros Pharmaceuticals
|
0.3 |
$7.5M |
|
1.0M |
7.48 |
C4 Therapeutics Com Stk
(CCCC)
|
0.3 |
$7.4M |
|
200k |
36.99 |
Magenta Therapeutics
|
0.3 |
$6.6M |
|
556k |
11.84 |
Logicbio Therapeutics
|
0.2 |
$5.0M |
|
689k |
7.28 |
Bolt Biotherapeutics
(BOLT)
|
0.2 |
$4.9M |
|
150k |
32.91 |
Jiya Acquisition Corp Com Cl A
|
0.2 |
$4.9M |
|
500k |
9.84 |
Cyclerion Therapeutics
|
0.2 |
$4.5M |
|
1.6M |
2.79 |
Health Sciences Acq Corp 2 Ord Shs
|
0.2 |
$4.5M |
|
400k |
11.19 |
Ngm Biopharmaceuticals
(NGM)
|
0.2 |
$4.2M |
|
144k |
29.07 |
Kymera Therapeutics
(KYMR)
|
0.2 |
$3.9M |
|
100k |
38.86 |
Dyne Therapeutics
(DYN)
|
0.1 |
$3.3M |
|
215k |
15.53 |
Vincerx Pharma *w Exp 12/24/202
|
0.1 |
$2.9M |
|
150k |
19.30 |
Aerpio Pharmaceuticals
|
0.1 |
$2.7M |
|
2.1M |
1.29 |
Bioatla
(BCAB)
|
0.1 |
$2.5M |
|
50k |
50.84 |
Bcls Acquisition Corp Com Cl A
|
0.1 |
$2.1M |
|
200k |
10.57 |
Helix Acquisition Corp Com Cl A
|
0.1 |
$2.0M |
|
200k |
10.20 |
Frazier Lifesciences Acqu Unit 12/09/2025
|
0.1 |
$2.0M |
|
200k |
10.16 |
5 01 Acquisition Corp Com Cl A
|
0.1 |
$2.0M |
|
200k |
9.99 |
Eucrates Biomedical Acqu Cor SHS
|
0.1 |
$2.0M |
|
200k |
9.98 |
Consonance Hfw Acquisition C Unit 99/99/9999
|
0.1 |
$2.0M |
|
200k |
9.76 |
Codiak Biosciences
|
0.1 |
$1.7M |
|
115k |
15.08 |
Pmv Pharmaceuticals
(PMVP)
|
0.1 |
$1.6M |
|
50k |
32.90 |
Arya Sciences Acqu Corp Iv Cl A
(ARYD)
|
0.1 |
$1.6M |
|
150k |
10.47 |
Repare Therapeutics Ord
(RPTX)
|
0.1 |
$1.5M |
|
50k |
30.70 |
Fs Development Corp Ii Com Cl A
|
0.1 |
$1.5M |
|
150k |
9.96 |
Meiragtx Holdings
(MGTX)
|
0.1 |
$1.4M |
|
95k |
14.43 |
Deerfield Healthcare Tech Ac *w Exp 07/16/202
|
0.1 |
$1.2M |
|
100k |
12.12 |
Turmeric Acquisition Corp Cl A
|
0.0 |
$977k |
|
100k |
9.77 |
Kinnate Biopharma
(KNTE)
|
0.0 |
$779k |
|
25k |
31.16 |
Eucrates Biomedical Acqu Cor *w Exp 10/23/202
|
0.0 |
$665k |
|
67k |
9.98 |
Lifesci Acquisition Ii Corp
|
0.0 |
$573k |
|
57k |
10.14 |
F-star Therapeutics
|
0.0 |
$498k |
|
46k |
10.83 |
Omega Alpha Spac Cl A
|
0.0 |
$495k |
|
50k |
9.90 |
Metacrine Ord
|
0.0 |
$386k |
|
62k |
6.21 |
Turmeric Acquisition Corp *w Exp 10/08/202
|
0.0 |
$326k |
|
33k |
9.78 |